Exercise in Hereditary ATTR (ATTRv) Amyloidosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Maia
About this trial
This study aims to explore the effects of a 12-week exercise intervention on the physical and mental health of people living with Hereditary ATTR (ATTRv) Amyloidosis, a rare genetic disease caused by mutations in the transthyretin gene, leading to the deposition of amyloid fibrils in nerves and organs.
Eligibility criteria
Qualifiers
ATTRv Amyloidosis patients living in Portugal;
Disease stage 1 or 2;
No medical contraindication for exercising;
Ability to provide informed consent.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Exercise
Treatment groups
42 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov